EKF Diagnostics Holdings Plc is a vitro diagnostics company, which engages in the designs and manufactures diagnostic equipment for use within point-of-care settings. The company is headquartered in Penarth, South Glamorgan and currently employs 297 full-time employees. The company went IPO on 2002-06-05. The firm develops and produces in-vitro diagnostic (IVD) devices and tests designed for use at or near the patient’s location. The company provides a suite of products for diabetes management, including glucose monitoring systems and associated consumables. The company offers devices, supplies, and consumables for measuring hemoglobin levels, including tools for detecting hemoglobin variants. The company also develops and supplies diagnostic and therapeutic enzymes, proteins, reagents, and biomaterials. The company provides precision fermentation, custom bioprocessing, and contract manufacturing services for pharmaceuticals and other biological products. The company supplies beta-hydroxybutyrate (HB) products used in ketone detection to support the diagnosis of diabetic ketoacidosis and other clinical conditions.
EKF Diagnostics Holdings PLC hisse başına yıllık % {var1} temettüye sahiptir ve % {var2} oranında bir getiri sunmaktadır. Temettü yıllık ödenmektedir ve son temettü hariç tarihi Nov 2, 2023 tarihindedir.
Dividend Yield
Yıllık Dividende
Özsermaye Tarihi
0.00%
$0.00
Nov 2, 2023
Ödeme Sıklığı
Ödeme Oranı
Yıllık
0.00%
Dividend History
Özsermaye Tarihi
Nakit Tutarı
Kayıt Tarihi
Ödeme Tarihi
Nov 2, 2023
$0.012
Nov 3, 2023
Dec 1, 2023
Nov 3, 2022
$0.012
Nov 4, 2022
Dec 1, 2022
Nov 4, 2021
$0.011
Nov 5, 2021
Dec 1, 2021
Nov 5, 2020
$0.01
Nov 6, 2020
Dec 1, 2020
Dividend Grafikleri
EKDHF Kâr Payları
EKDHF Dividend Growth (Yıllık Üstünlük)
Follow-Up Questions
EKF Diagnostics Holdings PLC'in şu anki temettü ödemesi ve yıllık temettüsü nedir?
EKF Diagnostics Holdings PLC'in temettü ödeme oranı nedir?
EKDHF'ün temettü dağıtım tarihi nedir?
EKF Diagnostics Holdings PLC ne sıklıkla temettü öder?